AstraZeneca PLC (AZN) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Astrazeneca Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.887 -- 00:00:04.950 Good morning to those joining from the UK and the US. 00:00:04.950 -- 00:00:09.796 Good afternoon to those in Central Europe, and good evening to those listening in Asia. 00:00:09.796 -- 00:00:14.841 Welcome, ladies and gentlemen, to AstraZeneca's Q1 2025 results conference call 00:00:14.841 -- 00:00:18.025 for investors and analysts. 00:00:18.025 -- 00:00:23.010 Before I hand over to AstraZeneca, I'd like to read the Safe Harbor Statement. 00:00:23.010 -- 00:00:27.135 The company intends to utilize the safe harbor provisions of the United States Private 00:00:27.135 -- 00:00:31.498 Securities Litigation Reform Act of 1995. 00:00:31.874 -- 00:00:35.977 This meeting may contain forward-looking statements with respect to the operations and 00:00:35.977 -- 00:00:39.333 financial performance of AstraZeneca. 00:00:39.333 -- 00:00:43.239 Although we believe our expectations are based on reasonable assumptions, 00:00:43.239 -- 00:00:48.146 by their very nature, forward-looking statements involve risks and uncertainties, and 00:00:48.146 -- 00:00:52.372 may be influenced by factors that could cause actual results to differ materially from 00:00:52.372 -- 00:00:57.099 those expressed or implied by these forward-looking statements. 00:00:57.099 -- 00:01:01.265 Any forward-looking statements made on this call reflect the knowledge and information 00:01:01.265 -- 00:01:04.610 available at the time of this call. 00:01:04.610 -- 00:01:09.590 The company undertakes no obligation to update forward-looking statements. 00:01:09.590 -- 00:01:13.795 Please also carefully review the forward-looking statements disclaimer in the slide deck 00:01:13.795 -- 00:01:17.119 that accompanies this conference call. 00:01:17.119 -- 00:01:21.345 There will be an op...